Sam Miller

Psych Trial Halted After Death; Curbing Phone Addiction; Most Worried Racial Group

Psych Trial Halted After Death; Curbing Phone Addiction; Most Worried Racial Group

The FDA halted patient enrollment in a phase III trial of evenamide in treatment-resistant schizophrenia following the sudden death of a participant, Newron Pharmaceuticals said. Magnetic seizure therapy achieved similar remission rates to electroconvulsive therapy in patients with bipolar depression, but was better tolerated and had less worsening of autobiographical memory, a randomized trial showed….

Read More
You Should Still Fact-Check the 'Expert Advice' in Google's AI Summaries

You Should Still Fact-Check the ‘Expert Advice’ in Google’s AI Summaries

Google’s AI search is getting a handful of updates designed to highlight first-hand information sourced from discussion boards and social media posts along with your trusted news sources and subscriptions. Notably, AI responses will now show “expert advice” pulled from online forums like Reddit, highlighting specific quotes and linking to discussions related to your search…

Read More
Three passengers now evacuated off Cape Verde

Three passengers now evacuated off Cape Verde

Some passengers have been evacuated from the MV Hondius cruise ship, off Cape Verde. The MV Hondius, which departed from Argentina on 1 April, had an outbreak of rodent-spread hantavirus on board. Three passengers on the ship have died and several more are either ill or displaying symptoms. The cruise ship is expected to depart…

Read More
VEGF Inhibitor Implant Preserves Visual Acuity, Retinal Anatomy in Wet AMD

VEGF Inhibitor Implant Preserves Visual Acuity, Retinal Anatomy in Wet AMD

DENVER — A sustained-release VEGF inhibitor implant outperformed standard anti-VEGF therapy for maintaining visual acuity in neovascular, or wet, age-related macular degeneration (AMD), showed a randomized trial reported here. Among patients with good baseline visual acuity, 74.1% maintained that status at 36 weeks with the axitinib implant OTX-TKI as compared with 55.8% taking standard-dose aflibercept…

Read More